$3.65
N/A
Últ. Act.: Oct 28, 4:46 PM
Camp4 Therapeutics (CAMP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Camp4 Therapeutics (CAMP) publicó su última previsión de julio 10, 2023 para Q2 2024. La compañía estimó ingresos en un rango de $67M - $73M para el período.
En comparación con la previsión anterior, Camp4 Therapeutics reducido redujo su previsión de ingresos desde un rango anterior de $72M - $78M.
Camp4 Therapeutics ha emitido 2 actualizaciones de orientación entre el abril 27, 2023 y el julio 10, 2023. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.21 | $-0.30 | $-0.48 |
| Actual | $-0.58 | $-0.32 | $-0.87 | $-0.55 |
| Surprise | -163.6% | -52.4% | -190.0% | -14.6% |
| Revenue | ||||
| Estimate | $1.8M | $1.2M | $538000 | $651998 |
| Actual | $1.8M | $1.3M | $348000 | $795000 |
| Surprise | -0.17% | +5.51% | -35.3% | +21.9% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.22 | $-0.17 | $-0.19 |
| Revenue | ||||
| Consensus | $1.8M | $1.8M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.58 | $-0.22 | -163.6 % |
| Q1 | May 7, 2026 | $-0.32 | $-0.21 | -52.4 % |
| Q4 | Mar 5, 2026 | $-0.87 | $-0.30 | -190.0 % |
| Q3 | Nov 6, 2025 | $-0.55 | $-0.48 | -14.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.78M | $1.78M | -0.17 % |
| Q1 | May 7, 2026 | $1.29M | $1.23M | 5.51 % |
| Q4 | Mar 5, 2026 | $348.00K | $538.00K | -35.3 % |
| Q3 | Nov 6, 2025 | $795.00K | $652.00K | 21.9 % |